Heparanase, Sulf1, and Sulf2 drive a range of processes in the tumor microenvironment, many of which, in the case of heparanase and Sulf2 promote tumor malignancy, and some, in the case of Sulf1 inhibit malignancy. The gene discussed is HPSE; the disease is neoplasm.